Compare SHFS & EDVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SHFS | EDVA |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | 3 |
| Industry | Finance: Consumer Services | Beverages (Production/Distribution) |
| Sector | Finance | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1M | 2.0M |
| IPO Year | 2021 | 2012 |
| Metric | SHFS | EDVA |
|---|---|---|
| Price | $0.06 | $0.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 70.9M | 553.0K |
| Earning Date | 11-11-2026 | 11-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 95.30 | 32.30 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,673,532.00 | $73,066.00 |
| Revenue This Year | N/A | $24,377.87 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.07 | $0.13 |
| 52 Week High | $28.32 | $0.33 |
| Indicator | SHFS | EDVA |
|---|---|---|
| Relative Strength Index (RSI) | 44.84 | 46.62 |
| Support Level | N/A | $0.17 |
| Resistance Level | $0.54 | $0.18 |
| Average True Range (ATR) | 0.07 | 0.01 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 0.54 | 82.24 |
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The company provides compliance and loan origination services to financial institutions that wish to offer business banking, private banking, and commercial banking services to clients operating in or adjacent to the state-legal cannabis industry. Its core service offerings include: Regulatory compliance consulting and technology, Cannabis-related deposit services and Lending services. The company generates revenue through fee income, investment income, and loan program income.
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.